Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings

Shares (Q2 2026)
7,459
Value
$555.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BBIO by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,459$555.5K<0.1%−3,624−32.7%ReducedHolders
Q1 202611,083$823.0K<0.1%+2,162+24.2%AddedHolders
Q4 20258,921$682.4K<0.1%+1,580+21.5%AddedHolders
Q3 20257,341$381.3K<0.1%+393+5.7%AddedHolders
Q2 20256,948$300.0K<0.1%+47+0.7%AddedHolders
Q1 20256,901$238.6K<0.1%+2,446+54.9%AddedHolders
Q4 20244,455$122.2K<0.1%−5,462−55.1%ReducedHolders
Q3 20249,917$252.5K<0.1%+320+3.3%AddedHolders
Q2 20249,597$243.1K<0.1%+328+3.5%AddedHolders
Q1 20249,269$286.6K<0.1%−6,387−40.8%ReducedHolders
Q4 202315,656$632.0K<0.1%−5,080−24.5%ReducedHolders
Q3 202320,736$546.8K<0.1%−9,460−31.3%ReducedHolders
Q2 202330,196$519.4K<0.1%−805−2.6%ReducedHolders
Q1 202331,001$514.0K<0.1%+29,597+2,108.0%AddedHolders
Q4 20221,404$10.7K<0.1%−557−28.4%ReducedHolders
Q3 20221,961$19.0K<0.1%+123+6.7%AddedHolders
Q2 20221,838$17.0K<0.1%+1,098+148.4%AddedHolders
Q1 2022740$8.00K<0.1%+671+972.5%AddedHolders
Q4 202169$1.00K<0.1%00.0%UnchangedHolders
Q3 202169$3.00K<0.1%−12−14.8%ReducedHolders
Q2 202181$5.00K<0.1%+43+113.2%AddedHolders
Q1 202138$2.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.